Sertraline-induced hepatotoxicity;Hepatotoxicidad asociada a sertralina

Farmacia Hospitalaria

Volumn 32, Issue 1, 2008, Pages 60-61

  Collados Arroyo, V ^a   Plaza Aniorte, J ^a   Hallal, H ^a   Perez Cuadrado E ^a  

^a HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; HYDROCHLOROTHIAZIDE; SERTRALINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; HUMAN; HYPERTENSION; LABORATORY TEST; LETTER; LIVER TOXICITY; MALE; CHEMICALLY INDUCED DISORDER; DYSURIA; LIVER FAILURE; MIDDLE AGED;

DYSURIA; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 54049097171     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(08)72814-9     Document Type: Editorial

References (7)

1. Informe sobre la salud del mundo en 2003, OMS. Disponible en: http://www.who.int/whr/2003/en/whr03_es.pdf
2. Andrade R., Camargo R., Lucena M.I., and González-Grande R. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf 3 (2004) 1-16
3. ® (sertralina) del medicamento.
4. Persky S., and Reinus J.F. Sertraline hepatotoxicity: a case report and review of the literature on selective serotonin reuptake inhibitor hepatotoxicity. Dig Dis Sci 48 (2003) 939-944
5. Lucena M.I., Carvajal A., Andrade R.J., and Velasco A. Antidepressant-induced hepatotoxicity. Expert Opin Drug Saf 2 (2003) 249-262
6. Carvajal Garcia-Pando A., Garcia del Pozo J., Sanchez A.S., Velasco M.A., Rueda de Castro A.M., and Lucena M.I. Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry 63 (2002) 135-137
7. Fartoux-Heymann L., Hezode C., Zafrani E.S., Dhumeaux D., and Mallat A. Acute fatal hepatitis related to sertraline. J Hepatol 35 (2001) 683-684